Quantitative Analysis of Pharmacokinetic Parameters Using Clinical Lung Dynamic Contrast-Enhanced MR Image

ZHONG Yi,LI Zhi-yong,HU Jia-ni,KANG Yan
DOI: https://doi.org/10.3969/j.issn.1005-3026.2013.10.034
2013-01-01
Abstract:Based on the dynamic contrast-enhanced MRI(DCE-MRI) data routinely acquired from a clinical lung,a new method called FCM-B RR was proposed for quantitative analysis.This method was based on the reference region model(RR),and combined with fuzzy C-mean(FCM) and B-Spline curve fitting techniques.The proposed FCM-B RR method not only solved the limitation of complex blood supply system,but also reduced the effect of noise on the quantitative analysis result.5 patients with pathologically proven lung cancer were examined using the proposed FCM-B RR method to demonstrate the feasibility and effectiveness.A significant difference(P 0.01) in K_(trans) between tumor tissue and normal tissue was found.It could be concluded that the proposed FCM-B RR method could be used for quantitative analysis of typical clinical lung DCE-MRI data,and the K_(trans) information has reference value for treatment and assesses the lung cancer.
What problem does this paper attempt to address?